Reading the tape
NYSE: CNC
Centene Corporation
Healthcare · Medical - Healthcare Plans
Market Cap
$26.36B
52w High
$64.15
52w Low
$25.08
P/E
-4.09
Volume
2.24M
Outstanding Shares
493.80M
Price vs Fundamentals
Why The Stock Is Moving
Mixed / unclearLow confidence
1Y Price: -10.42%Revenue (TTM): 17.02%FCF (TTM): 325.34%P/FCF: 3rd pct
What changed
The stock fell 10.42% over the last year. Revenue grew 17.02% over the trailing twelve months. Operating margin moved from 2.13% to -3.68%. Free cash flow grew 325.34% over the trailing twelve months.
What the market seems to be pricing
The stock has moved lower against modestly improving underlying metrics. The operating data does not yet tell a clear story — the move may reflect sentiment, sector rotation, or macro factors rather than company-specific earnings power.
What would invalidate this read
Operating margin currently stands at -3.68%. A decisive move in revenue — currently up 17.02% — would be the clearest signal to resolve the ambiguity.
Company profile
Centene Corporation operates as a multi-national healthcare enterprise that provides programs and services to under-insured and uninsured individuals in the United States.
CEOSarah London
SectorHealthcare
IndustryMedical - Healthcare Plans
Employees60,400
IPO dateDec 13, 2001
Valuation
Forward P/E—
EV/EBITDA-4.10
Enterprise value$21.1B
Price / Book1.32
Stock splits
Feb 7, 2019↑ Forward
Every 1 shares became 2
Feb 20, 2015↑ Forward
Every 1 shares became 2
Dec 20, 2004↑ Forward
Every 1 shares became 2
Jul 14, 2003↑ Forward
Every 2 shares became 3
Profitability & growth
Standard profitability metrics can be misleading for financial/insurance companies. GAAP requires unrealized investment gains/losses in net income (affecting ROE), and margins are blended across diverse business segments.
Revenue growth7.13%
Gross margin14.93%▲18.57%vs FY2024
Operating margin-3.68%▼300.89%vs FY2024
ROE-33.44%▼367.25%vs FY2024
Analyst consensus
RatingBuy
Target price$51.00▼4.46%
26
Buy
16
Hold
1
Sell
Analyst ratings tend to be lagging indicators. Use as one signal among many.
Earnings
Full quarter-by-quarter history of actuals vs estimates. Switch into compare mode to inspect one metric year-over-year.
Next report
Jul 28, 2026
Q3 FY26 · EPS est $1.05 · Revenue est $47.51B
View